Viatris (VTRS) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Viatris Inc (VTRS) Prix de l'Action, Cotation, Actualités et Historique

VTRSNASDAQ

Trade with Public

Trade with Public

$18.26

-0.39-2.12%

Dern. MÀJ: Oct 20, 7:07 AM

$18.30

-0.36-1.9%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

-

Clôture

$18.26

Volume / Moy.

1.31K / 9.30M

Fourchette Journalière

- - -

Plage 52 Sem.

9.92 - 18.75

Capitalisation Boursière

$21.02B

Ratio P/E

-

Rendement des Dividendes

2.63%

Échange

NASDAQ

RSI

65

Intérêt à Découvert

3.67%

Jours pour Couvrir

4.17

Actualités Récentes de Viatris Inc.

Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy

Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor, Energy Transfer buys Vacquero Midstream.

Caroline Ryan

Viatris Bets Big on Non-Opioid Painkillers With Pacira Buyout

Pacira BioSciences stock surges 44% after Viatris announces a $1.65 billion takeover deal to expand its pain treatment portfolio.

Vandana Singh

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields

Analysts review high-yield healthcare stocks CVS, Viatris and Medtronic, citing ratings, price targets, dividend yields and recent company news.

Avi Kapoor

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook

Viatris sells Tyrvaya to Harrow for up to $100 million, raises 2026 guidance after second-quarter earnings and revenue beat estimates.

Vandana Singh

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ratings page provides latest analyst takes on top stocks, sorted by accuracy. Ratings for three high-yielding health care stocks: VTRS, MDT, GSK. VTRS to report Q2 results on Aug.6, MDT recalls certain catheter system, GSK reports positive trial results. Benzinga Pro's newsfeed provides real-time alerts.

Avi Kapoor

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

2.33B

Flux de Trésorerie d'Investissement (TTM)

-84.30M

Flux de Trésorerie de Financement (TTM)

-1.91B

Flux de Trésorerie Libre (TTM)

1.81B

Dépenses en Capital (TTM)

-518.60M

Variation Nette de la Trésorerie (TTM)

335.60M

Tendances et prévisions des analystes

2

1

mai

3

1

sept.

1

oct.

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

3.5

Conserver

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$33.08B

Ratio P/E (TTM)

-

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

1.44

Ratio P/B (TTM)

1.47

Rendement des Bénéfices % (TTM)

-2.03%

Rendement des Bénéfices % (FWD)

-

EV / EBITDA (TTM)

12.62

Prix / EBITDA (TTM)

8.12

Prix / Flux de Trésorerie Libre (TTM)

11.74

Valeur Comptable / Action

$12.42

Dette Entreprise

Dette Totale

$13.35B

Dette à Long Terme

$11.61B

Émission de Dette à Long Terme (TTM)

$1.30B

Remboursement de la Dette à Long Terme (TTM)

-$2.23B

Trésorerie Totale

$886.50M

Dette sur Capitaux Propres

0.96

Émission de Dette (TTM)

-$922.30M

Remboursement de la Dette (TTM)

-$2.23B